| ABBOTT LABORATORIES |
| USA |
| Gesundheit |
| US0028241000 / 850103 |
| ABL (Frankfurt) / ABT (NYSE) |
| FRA:ABL, ETR:ABL, ABL:GR, NYSE:ABT |
| S&P500 |
| https://www.abbott.com/ |
|
Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of health care products worldwide. It operates across four key segments: Established Pharmaceutical Products, Diagnosti..
>Volltext.. |
| 157030.13 Mio. EUR |
| 162010.15 Mio. EUR |
| 38521.13 Mio. EUR |
| 9916.18 Mio. EUR |
| 5648.51 Mio. EUR |
| 3.25 EUR |
| 12284.22 Mio. EUR |
| 7405.64 Mio. EUR |
| 8312.88 Mio. EUR |
| 0.54 |
| -6.86% |
| -57.09% |
| 2.06 EUR |
| 2.31% |
| 2.35% |
| 15.01.26 - 0.542178€ 15.10.25 - 0.50622€ >weitere anzeigen... |
| ABBOTT LABORATORIES, ABBOTT LABS, ABBOTT LAB, (ABT), ABT |
| 31.03.26 |
|